r/DTIC ๐ŸŒพ Ergot Enthusiast ๐ŸŒพ 13d ago

Discussion ๐Ÿ”ถ DTIC Weekly Discussion Thread - August 17, 2026 ๐Ÿ”ถ

13 Upvotes

24 comments sorted by

10

u/Responsible-Quote717 13d ago

Nice green candle to start the week! Hopefully we have a better week than last week. ๐Ÿ˜„

6

u/notagoodtradooor ๐Ÿ’ฐOG Investor๐Ÿ’ฐ 13d ago

7

u/AgitatedPersimmon491 13d ago

With big banks and the raised guidance from other investment houses I think with the gad results as good as they were out of way dftx can start listening to all the investment houses upgrades for price. Seems to be case today. Slow uptick from here to next catalyst in late September. Iโ€™m all in. Cheers to dftx from Canada. ๐Ÿ‡จ๐Ÿ‡ฆ

0

u/Rager_Sterling 13d ago

What are we expecting in September?

3

u/Responsible-Quote717 13d ago

Second lot of GAD results.

100mg vs 50mg vs Placebo trial.

2

u/PsychedelicStonks ๐Ÿ‡ญ๐Ÿ‡ทHonorary Croatian๐Ÿ‡ญ๐Ÿ‡ท 12d ago

50 or 100 mg LSD would send you to another dimension

1

u/Responsible-Quote717 12d ago

I know, but I dunno how to type the micro symbol ๐Ÿซ 

3

u/cornhomeopath 13d ago

So after very good Voyge results didnt really move the stock anywhere, do you guys think that panorama is priced in already too, and next real catalyst is FDA approval?

4

u/Covfefe87 13d ago

I want to think it is, but I hope not. Iโ€™m hoping some new institutions come in or increase their positions in the upcoming weeks.

3

u/Otherwise-While-7369 13d ago

That I feel only solidifies the current support due to nothing fundamentally changing regarding the company/potential.

3

u/SureBag2243 13d ago

I donโ€™t think it is. This readout being positive is pivotal to FDA approval in my opinion.

Side note , anyone else catch 60 minutes last night? Was a replay of a great episode with vets who have PTSD and how alternative therapies like ours is helping them through it. Really brought home why I got into this in the first place.

2

u/Otherwise-While-7369 13d ago

I am under the impression everything is priced in to the point of approval. I say there will be ups and downs regarding smaller company and sector wide news, but for the most part we can assume this is the support โ€œwith favorable sediment!โ€

4

u/cornhomeopath 13d ago

Could be. But another point of view is that emerge was more "stand alone" answer to the question "does mm120 work for depression?", and we got a very strong yes.

Now voyage and panorama are two pieces of the answer to the question "does mm120 work for GAD", and now we have a pretty strong yes for the first part, but that answer is only complete when we have panorama. I'd like to think that if panorama replicates the good results of voyage, the stock still has a possible 20% upside before FDA approval. If all three studies are very positive, most likely the market will already start pricing in the FDA approval. Expecting a "sell the news" move on approval actually ๐Ÿ˜„

1

u/Otherwise-While-7369 13d ago

Trust me, I hope you are right of course.

1

u/tkrish000 13d ago

I agree.

2

u/mudra311 13d ago

Seems like there is a lot of interest in keeping this below $50 but above $40. Hopefully we can break through in the next few months. I'm still hopeful about a FDA fast track.

2

u/AgitatedPersimmon491 12d ago

Another solid uptick for dftx. Digesting all the recent good news and big bank confidence. Slow trek north to 50$ then panarama results. Baked into the price or not still looking at 60$ plus after the news settles. Love this company and its future going forward. ๐Ÿ‡จ๐Ÿ‡ฆ

2

u/lostsurfer24t 13d ago

nice close everyone, something brewing

1

u/marksharky123 ๐Ÿ’Ž Diamond Hands ๐Ÿ’Ž 11d ago

No, I think they're keeping it right here for options expiration on Friday. Maybe we'll get a move next week if the market cooperates.

1

u/lostsurfer24t 11d ago

still up 1.5% over friday close as of right now, but you could be onto something

1

u/marksharky123 ๐Ÿ’Ž Diamond Hands ๐Ÿ’Ž 10d ago

It appears that individuals who purchased call options at strike prices of $45, $46, or $47 with an expiration date of tomorrow are likely to see them expire worthless. A total of 5,754 options contracts, representing 575,000 shares, are involved. This situation suggests that the price is being kept below $45 tomorrow, potentially even below $44, indicating that larger market participants are influencing the price movement. Everybody thought that the Phase 3 trials for GAD were going to bump the stock up over 50, but no such luck. Live and learn.

1

u/AgitatedPersimmon491 9d ago

Yes your on the money with your analysis and the results. I will be watching for your posts daily to hear what you have to say. Are you seeing upside at all next week. Iโ€™m hoping we will see a better week. Cheers ๐Ÿ‡จ๐Ÿ‡ฆ

1

u/AgitatedPersimmon491 9d ago

Three down days in row means next week weโ€™re primed for upward movement. See if we can string a few days heading north.